JPRN-UMIN000043561招募中未知
Multicenter Study of Circulating Tumor DNA in Patients with Pancreatic Cancer Using a Personalized Panel - ARTEMIS-PC
ational Cancer Center Hospital East0 个研究点目标入组 150 人开始时间: 2021年3月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Common exclusion criteria for both the unresectable and resectable pancreatic cancer patient cohorts 1.Synchronous double/multiple cancer or metachronous double/multiple cancer with progression free period of 2 years or shorter. 2.Women who are pregnant or planning to become pregnant. 3.Judged by the investigator as being unsuitable for participation in the study.
研究者
相似试验
招募中
不适用
Observational Study of circulating-tumor DNA in Patients with Gastrointestinal CancerEsophageal cancer, Esophago-gastric junctional cancer, Gastric cancerJPRN-UMIN000042003ational Cancer Center Hospital East200
招募中
不适用
A Phase III Trial of Treatment Intensification in Stage II-III Colon Cancer Patients with Positive MRD during Adjuvant ChemotherapyKCT0007644Seoul National University Hospital236
已完成
不适用
Prospective Evaluation of Circulating Tumour DNA (ctDNA) as Molecular Monitoring Tool and Prognostic Biomarker in Resectable Pancreatic AdenocarcinomasC25Malignant neoplasm of pancreasDRKS00010992niversitätsklinikum Freiburg25
进行中（未招募）
4 期
CUARTET StudyMetastatic Castration-sensitive Prostate CancerJPRN-jRCTs071200040emura Hirotsugu100
已完成
不适用
Quantification of Circulating tumor DNA derived Structural variants to assess treatment response in metastatic prostate cancer patientsprostate carcinoma10038364prostate cancerNL-OMON43524Erasmus MC, Universitair Medisch Centrum Rotterdam285